Liver samples from patients with NAFLD and NASH demonstrated increased eIF2α phosphorylation and HSPA5 expression, although other ER stress markers were not increased (45). This evidence concerns the gene HSPA5 and metabolic dysfunction-associated steatotic liver disease.